---
reference_id: "PMID:30878128"
title: "ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer."
authors:
- Rosas G
- Ruiz R
- Araujo JM
- Pinto JA
- Mas L
journal: Crit Rev Oncol Hematol
year: '2019'
doi: 10.1016/j.critrevonc.2019.02.006
content_type: abstract_only
---

# ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer.
**Authors:** Rosas G, Ruiz R, Araujo JM, Pinto JA, Mas L
**Journal:** Crit Rev Oncol Hematol (2019)
**DOI:** [10.1016/j.critrevonc.2019.02.006](https://doi.org/10.1016/j.critrevonc.2019.02.006)

## Content

1. Crit Rev Oncol Hematol. 2019 Apr;136:48-55. doi: 
10.1016/j.critrevonc.2019.02.006. Epub 2019 Feb 16.

ALK rearrangements: Biology, detection and opportunities of therapy in non-small 
cell lung cancer.

Rosas G(1), Ruiz R(2), Araujo JM(3), Pinto JA(3), Mas L(4).

Author information:
(1)Departamento de Patología, Instituto Nacional de Enfermedades Neoplásicas, 
Av. Angamos Este, 2520, Surquillo, Lima 34, Peru.
(2)Unidad de Investigación Básica y Traslacional, Oncosalud-AUNA, Av. Guardia 
Civil 571, San Borja, Lima 41-Peru; Departamento de Medicina Oncológica, 
Instituto Nacional de Enfermedades Neoplásicas, Av. Angamos Este, 2520, 
Surquillo, Lima 34-Peru.
(3)Unidad de Investigación Básica y Traslacional, Oncosalud-AUNA, Av. Guardia 
Civil 571, San Borja, Lima 41-Peru.
(4)Unidad de Investigación Básica y Traslacional, Oncosalud-AUNA, Av. Guardia 
Civil 571, San Borja, Lima 41-Peru; Departamento de Medicina Oncológica, 
Instituto Nacional de Enfermedades Neoplásicas, Av. Angamos Este, 2520, 
Surquillo, Lima 34-Peru. Electronic address: lmasl@hotmail.com.

The ALK receptor tyrosine kinase (ALK) gene encodes a transmembrane protein 
rearranged in 2-7% of non-small cell lung cancer (NSCLC) cases. This gene has 
become the second most studied therapeutic target after EGFR due to the implied 
therapeutic opportunities. While the diagnostic of ALK rearrangements is well 
established, small molecules targeting ALK are in constant evolution because 
tumor cells eventually will develop mechanisms of resistance. In this review we 
describe the biology of the ALK gene, alterations, epidemiology, diagnostic 
tests as well as strategies of treatment.

Copyright © 2019 Elsevier B.V. All rights reserved.

DOI: 10.1016/j.critrevonc.2019.02.006
PMID: 30878128 [Indexed for MEDLINE]